BridgeBio
Founded in 2015, BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. They are based in Palo Alto, California.
Last updated on
About BridgeBio
Founded
2015Estimated Revenue
$50M-$100MEmployees
251-1KFunding / Mkt. Cap
$2BCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
87NAICs Code
54Location
City
Palo AltoState
CaliforniaCountry
United StatesTech Stack (90)
